title: Intrahepatic cholangiocarcinoma: management options and emerging therapies.
authors.affiliation: Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: Rebecca M
authors.initials: RM
authors.lastname: Dodson
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Weiss
authors.forename: David
authors.initials: D
authors.lastname: Cosgrove
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Herman
authors.forename: Ihab
authors.initials: I
authors.lastname: Kamel
authors.forename: Robert
authors.initials: R
authors.lastname: Anders
authors.forename: Jean-Francois H
authors.initials: JF
authors.lastname: Geschwind
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Pawlik
mesh_terms: D001650:Bile Duct Neoplasms; D001653:Bile Ducts, Intrahepatic; D018281:Cholangiocarcinoma / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D012307:Risk Factors; D015996:Survival Rate
keywords: AJCC; American Joint Committee on Cancer; EGFR; HBV; HCC; HCV; IBD; ICC; LN; PSC; VEGF; epidermal growth factor receptor; hepatitis B virus; hepatitis C virus; hepatocellular carcinoma; inflammatory bowel disease; intrahepatic cholangiocarcinoma; lymph node; primary sclerosing cholangitits; vascular endothelial growth factor